Professor Kunal Roy

Drug Theoretics and Cheminformatics Laboratory, Department of Pharmaceutical Technology, Jadavpur University, Kolkata 700 032, India
 

Biography hide/show

Dr. Kunal Roy (https://sites.google.com/site/kunalroyindia/) is a Professor in the Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India. He has been a recipient of Commonwealth Academic Staff Fellowship (University of Manchester, 2007) and Marie Curie International Fellowship (University of Manchester, 2013). The field of his research interest is QSAR and Molecular Modeling. Dr. Roy has published more than 250 research papers in refereed journals. He has also coauthored QSAR related books entitled “Understanding the Basics of QSAR for Applications in Pharmaceutical Sciences and Risk Assessment” (Elsevier, 2015) and “A Primer on QSAR/QSPR Modeling: Fundamental Concepts” (Springer, 2015) and edited “Quantitative Structure-Activity Relationships in Drug Design, Predictive Toxicology, and Risk Assessment” (IGI Global, 2015). His current h-index is 35 (SCOPUS). Prof. Roy is the editor-in-Chief of International Journal of Quantitative Structure-Property Relationships (IJQSPR) [IGI Global] and an Associate Editor of Molecular Diversity [Springer] . He is also a member of the Editorial Advisory Boards of (1) European Journal of Medicinal Chemistry [Elsevier], (2) Journal of Molecular Graphics and Modelling [Elsevier] (3) Chemical Biology and Drug Design [Wiley], (4) Expert Opinion on Drug Discovery [Informa], (5) Letters in Drug Design and Discovery [Bentham], (6) Current Computer-Aided Drug Design [Bentham]. Prof. Roy is also a recipient of several awards including Bioorganic and Medicinal Chemistry Most Cited Paper 2003-2006, 2004-2007 and 2006-2009 Awards from Elsevier, The Netherlands, Bioorganic and Medicinal Chemistry Letters Most Cited Paper 2006-2009 Award from Elsevier, The Netherlands.

Publications

by Indrani MITRA, Achintya SAHA, Kunal Roy
doi: 10.3797/scipharm.1208-01, published: 1 January 2013
by Indrani MITRA, Achintya SAHA, Kunal Roy
doi: 10.3797/scipharm.1011-02, published: 1 January 2011
by Supratik Kar, Kunal Roy
doi: 10.1517/17460441.2013.761204, published: 1 March 2013
by Kunal Roy
doi: 10.1517/17460441.2.12.1567, published: 1 December 2007
by Kunal Roy, Gopinath Ghosh
doi: 10.1111/j.1747-0285.2008.00712.x, published: 1 November 2008
by Supratik Kar, A.P. Harding, Kunal Roy, P.L.A. Popelier
doi: 10.1080/10629360903568697, published: 1 January 2010
by J. Leonard, Kunal Roy
doi: 10.1080/10559610390484221, published: 1 January 2003
by Kunal Roy, A. U. De, Chandana Sengupta
doi: 10.1080/10559610213503, published: 1 March 2002
by Kunal Roy, A. U. De, Chandana Sengupta
doi: 10.1080/10559610213502, published: 1 March 2002
by Kunal Roy, J. Thomas Leonard
doi: 10.1021/ci050205x, published: 1 September 2005
by A.A. Toropov, Kunal Roy
doi: 10.1021/ci034200g, published: 26 January 2004
by Supratik Kar, Kunal Roy
doi: 10.1016/j.jhazmat.2009.12.038, published: 1 May 2010
by Prosenjit Bhattacharya, J. Thomas Leonard, Kunal Roy
doi: 10.1016/j.bmc.2004.11.022, published: 1 February 2005
by Kunal Roy, Gopinath Ghosh
doi: 10.1007/s00894-005-0033-7, published: 26 February 2006
by Joseph Thomas Leonard, Kunal Roy
doi: 10.1002/qsar.200630140, published: 1 September 2007